Therapeutic potential of TAS-115 via c-MET and PDGFRα signal inhibition for synovial sarcoma
Shutaro Yamada(Osaka University), Norifumi Naka(Osaka International Cancer Institute)
Cited by 18
Related Papers
Synovial Sarcoma Is a Stem Cell Malignancy
|Stem Cells|2010|202
Combined targeting of mTOR and c-MET signaling pathways for effective management of epithelioid sarcoma
|Molecular Cancer|2014|47
Establishment of a novel clear cell sarcoma cell line (Hewga-CCS), and investigation of the antitumor effects of pazopanib on Hewga-CCS
|BMC Cancer|2014|34